MIAMI–November 14, 2022, Heru Inc. announced that it has passed the clinical milestone of over 100,000 patient eyes that have been examined using its wearable technology since the company’s commercial launch a little over a year ago.
“We are thrilled to see the rapid adoption of the Heru platform,” said Mohamed Abou Shousha, MD, PhD, Heru’s founder, and CEO. “The momentum our technology is gaining in the vision care and health and wellness communities affirms our mission and further drives us to propel the continued development of our platform forward.”
Heru was born out of the University of Miami’s Bascom Palmer Eye Institute and developed in partnership with researchers, scientists, and engineers following more than a decade of clinical study. Well known as an incubator of novel, disruptive technologies, Bascom Palmer’s core tenets of rigorous research and innovation have fed Heru’s rapid development of new testing modalities, allowing eyecare providers to easily fit a multitude of exams into their practice workflow.
“Heru’s technology is the epitome of what we aim to achieve in terms of clinical innovation,” said Eduardo C. Alfonso, MD, Director of the Bascom Palmer Eye Institute and Chairman of Heru’s Medical Advisory Board.
An internationally renowned physician, surgeon, researcher, and professor, Dr. Alfonso leads the acclaimed institution whose research is aimed at identifying sight-threatening eye conditions and developing groundbreaking technology that challenges the status quo to diagnose, treat and manage those vision disorders.
“From the technology’s infancy in the clinical research labs at Bascom Palmer to now examining over 100,000 eyes, I am exceptionally proud of what Heru has achieved. This platform is improving the quality of life for patients living with vision disorders around the world.”
Heru delivers nine vision exams, supported with five reimbursable CPT medical billing codes, in a single, wearable AR/VR headset. The platform replaces several legacy diagnostic devices and exceeds traditional standards of care in usability, cost, size, and portability.
About Heru
Heru Inc. (www.seeheru.com) is a medical software company focused on the development of next-generation vision exams leveraging commercially available AR/VR head-mounted displays. The company pioneered the first multi-modal wearable solution, which has revolutionized healthcare by introducing several vision exams within a single platform. The platform’s dark adaptation and contrast sensitivity exams establish a market-leading AMD portfolio that may aid physicians in detecting subclinical AMD and monitoring disease progression. Heru is leveraging its award-winning platform to build a comprehensive solution that is strongly correlated to the current standard of care and exceeds traditional standards of care in usability, cost, size, and portability. Future development includes therapeutic applications for personalized augmented vision correction.
Brandon Barber
Chief Marketing Officer
media@heru.net
By Greg Caldwell, OD, FAAO There are times in the life of every practitioner when making a diagnosis can be…
Heru Wins Prestigious CES Innovation Award for 2nd Consecutive Year with Expanded, Multimodal Platform MIAMI, FL (November 17, 2022) — Today,…
Shine a Spotlight on AMD: 5 Reasons to Screen Your Patients by Milan Lockhart, OD As our patient's age, their eyes…
Miami, FL (October 31, 2022) – Today, Heru announced several key executive appointments across its leadership team and board of…
By Greg Caldwell, OD, FAAO 196 million people worldwide are impacted by age-related macular degeneration (AMD), with as many as…